huberman retatrutide Andrew Huberman, Ph.D. (@hubermanlab) • Instagram photos and videos Huberman Lab - Listen here

Research suggests: Synergistic effects on weight loss exceeding predictions from single or dual receptor activation Complementary regulation of both energy intake (primarily GLP-1 and GIP) and energy expenditure (primarily glucagon) Balanced effects on glucose metabolism through multiple mechanisms Potential cardiovascular benefits through lipid metabolism improvements and blood pressure reduction [CALLOUT BOX Highlighted] Mechanistic Insight: GLP3 s triagonist approach represents an evolution beyond dual GLP-1/GIP agonism, with the addition of glucagon receptor activation appearing to enhance weight loss efficacy and metabolic benefits

The medication doesnt clear from your system between doses

The mechanism also explains why medical oversight matters

No physical address or verifiable business identity